Epstein-Barr Virus Capsid Antigen BFRF3 protein (Recombinant) (STJP000428)


Current Stock:
Host: E.coli
Applications: ELISA, WB
Short Description: Recombinant-Epstein-Barr Virus Capsid Antigen BFRF3-protein was developed from e.coli. For use in research applications.
Conjugation: Unconjugated
Formulation: Lyophilized from 25mM Tris-Hcl pH 7.2, 1mM EDTA and 50% glycerol.
Dilution Range: Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers.
Storage Instruction: The lyophilized protein is stable for at least 2 years from date of receipt at-20°C. Upon reconstitution, this protein can be stored in working aliquots at 2-8°C for one month, or at-20°C for six months, with a carrier protein without detectable loss
Immunogen Region: Immunodominant Fragment
Background Recombinant EBV p18 encodes the immunodominant sequences of theEpstein-Barr Viruscapsid p18protein.This molecule has a calculated mass of approximately 13kDa. Recombinant EBV p18 contains an N terminal GST purification tag and migrates as an approximately 39 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance